Results 111 to 120 of about 9,878 (194)

Psychedelics, entactogens and psychoplastogens for depression and related disorders

British Journal of Pharmacology, Volume 183, Issue 14, Page 3897-3919, July 2026.
Currently, the most actively investigated rapidly acting antidepressants, anxiolytics and/or anti PTSD agents, include psychedelics e.g. psilocybin, LSD, N,N‐dimethyltryptamine, ayahuasca; non‐hallucinogenic entactogens, e.g. MDMA; psychoplastogens which rapidly promote neuroplasticity, e.g.
Daniel Hoyer
wiley   +1 more source

Gastroenterological Society of Australia Position Statement on the Assessment and Management of Idiopathic Gastroparesis

Journal of Gastroenterology and Hepatology, Volume 41, Issue 7, Page 2043-2061, July 2026.
The first Australian guidance document on the assessment and management of idiopathic gastroparesis (IGP) reconceptualises IGP as a sensorimotor disorder. It proposes a novel multidisciplinary treatment algorithm and 20 high‐consensus recommendations, addressing common overlapping disorders, and providing clear guidance on associated disordered eating ...
Trina Kellar, Chamara Basnayake, Jessica Biesiekierski, Rebecca Burgell, Jessica Fitzpatrick, Geoffrey Hebbard, Vincent Ho, Hannah Kim, Simon R. Knowles, Christopher K. Rayner, May Wong, Nicholas J. Talley   +11 more
wiley   +1 more source

P01-101 - Unique: Assessing the Efficacy of Quetiapine Fumarate Augmentation of SSRI or SNRI Treatment in SSRI- or SNRI-resistant Major Depressive Disorder

, 2010
ObjectivesThe UNIQUE study assessed the effect of Quetiapine fumarate augmentation on the overall depression status of patients with major depressive disorder and who did not respond to any acute treatment with selective serotonin reuptake inhibitors ...
J. Lejeune, C. Taeter, V. Duquenne, N. Goodman   +3 more
core   +1 more source

Differences between SSRI and SNRI in depression treatment

Quality in Sport
Introduction Depressive disorders represent a significant health problem worldwide. With the development of pharmacotherapy, selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) have become preferred
Mateusz Grego, Katarzyna Grego, Łukasz Stojak, Dariusz Popiela, Karina Urbańska, Filip Kwiatkowski, Mateusz Baczewski, Witold Czyż   +7 more
doaj   +1 more source

The Converging Effects of Different Categories of Antidepressants on the Brain: A Systematic Meta‐Analysis of Public Transcriptional Profiling Data From the Hippocampus and Cortex

Journal of Neurochemistry, Volume 170, Issue 7, July 2026.
Understanding the congruent effects of different types of antidepressant treatments on sensitive brain regions, such as the hippocampus and cortex, can highlight essential mechanisms of action. We used a systematic meta‐analysis of public transcriptional profiling datasets to identify genes and functional gene sets that are differentially expressed ...
Eva M. Geoghegan, Megan H. Hagenauer, Erin Hernandez, Sophia Espinoza, Elizabeth I. Flandreau, Phi T. Nguyen, Adrienne N. Santiago, Mubashshir Ra’eed Bhuiyan, Sophie Mensch, Stanley J. Watson Jr., Huda Akil, René Hen   +11 more
wiley   +1 more source

Expert Clinical Consensus on Body Surface Gastric Mapping Phenotypes for Gastroduodenal Disorders: ‘Auckland Classification’ v1.0

Neurogastroenterology &Motility, Volume 38, Issue 7, July 2026.
The Auckland Classification, derived by international consensus, presents a structured framework for BSGM‐defined patient phenotypes. This classification forms a foundation for research, further validation, and a pathway for integrating BSGM into clinical care. ABSTRACT Introduction Chronic gastroduodenal disorders remain challenging to manage, and new
Chris Varghese, Nicky Dachs, Gabriel Schamberg, Thomas Abell, Mohammad Al‐Haddad, Timothy Robert Angeli‐Gordon, Shahin Ayazi, Homira Ayubi, Mohammad Bashashati, Robert Bulat, Stefan Calder, Christopher Brian Cederwall, Bianca Chang, Leo Cheng, John Clarke, Charlotte Daker, Peng Du, Jon Erickson, Sven Eriksson, Asma Fikree, Daphne Foong, Mark Fox, Uday Chand Ghoshal, Mahesh Goenka, Rehan Haidry, William L. Hasler, Bu'Hussain Hayee, Vincent Ho, Gerald Holtman, Anthony Robert Hobson, I‐Hsuan Huang, Daniel Keszthelyi, Sahib S. Khalsa, Natasha Koloski, Braden Kuo, David Kunkel, Mikaela Law, David Levinthal, Joy J. Liu, Prateek Mathur, Baharak Moshiree, Leila Neshatian, Catherine Ngo, Linda Nguyen, Nicholas R. Oblizajek, Henry P. Parkman, Sanjay Pandanaboyana, Alexander Podboy, Ali Rezaie, Amol Sharma, Sam Simmonds, Jonathan Sivakumar, Jarongkorn Sirimongkolkasem, Irene Sonu, Abigail Stocker, Joseph Sujka, Jan Tack, Charles Verdonk, Xiao Jing Wang, Douglas Weinstein, John Windsor, Nicha Wongjarupong, William Xu, Natalia Zarate‐Lopez, Christopher N. Andrews, Armen A. Gharibans, Greg O'Grady   +66 more
wiley   +1 more source

Acute prefrontal hemodynamic responses to intermittent theta burst stimulation correlate with current depression and episode recurrence: A cross‐sectional study

Psychiatry and Clinical Neurosciences, Volume 80, Issue 7, Page 616-625, July 2026.
Background Mounting evidence has indicated that multiple major depressive disorder (MDD) episodes are correlated with brain morphometric changes that confer an increased recurrence risk. Functional abnormalities underlying this recurrent vulnerability remain underexplored.
Minxia Jin, Adam W.L. Xia, Wanda M.W. Chau, Nancy M.X.Y. Shi, Penny P. Qin, Bella B.B. Zhang, Rebecca L.D. Kan, Alvin H.P. Tang, Tim T.Z. Lin, Sharie X. Wang, Dicky W.S. Chung, Frank Padberg, Georg S. Kranz   +12 more
wiley   +1 more source

Comparison of the cost-effectiveness of milnacipran (a SNRI) with TCAs and SSRIs: a modeling approach

, 1999
SummaryA simulation model based on the theory of clinical decision analysis was used to compare outcomes and costs when treating patients with major depressive episodes using either a selective serotonin re-uptake inhibitor (SSRI) or a tricyclic ...
G Berdeaux, F Fagnani, R Dardennes, A Lafuma   +3 more
core   +1 more source

Management of antidepressant-induced bruxism [PDF]

Mental Health Clinician
Hayley Cliatt, PharmD, Andrew M. Williams, PharmD, BCPP, Jessa Koch, PharmD, BCPP   +2 more
doaj   +1 more source

A role for nuclear β-catenin in SNRI antidepressant-induced hippocampal cell proliferation

, 2012
Increasing evidences have been accumulated during recent years suggesting a role for antidepressant drugs (ADs) as hippocampal neurogenesis enhancers, but the information about the transductional mechanisms involved in this response is very limited.
Valdizán, Elsa M., Mostany, Ricardo, Pazos, Ángel   +2 more
core   +1 more source